Skip to main content

Bangladesh approves proposal of producing Russian, Chinese COVID-19 vaccines

Abstract : The Bangladeshi government on Wednesday gave the greenlight to a proposal of producing Chinese and Russian COVID-19 vaccines in the country.

DHAKA, April 28 (Xinhua) — The Bangladeshi government on Wednesday gave the greenlight to a proposal of producing Chinese and Russian COVID-19 vaccines in the country.

Bangladesh’s Cabinet Committee on Economic Affairs approved the proposal to produce the vaccines — China’s Sinopharm and Russia’s Sputnik V.

Shahida Akhter, a senior Cabinet Division official, said several leading Bangladeshi pharmaceutical firms in collaboration with the Chinese and Russian companies will produce the vaccines.

The decision came days after Dhaka suspended the first dosing of the Oxford-AstraZeneca vaccine on a supply crunch.

Amid uncertainty over the timely arrival of the next COVID-19 vaccine shipment from India, the Bangladeshi government halted administering the first dose of the AstraZeneca vaccine across the country from Monday.

Nearly 6 million people have so far received the first dose of the vaccine in Bangladesh.

Prime Minister Sheikh Hasina inaugurated the country’s COVID-19 vaccination drive on Jan. 28 to rein in the pandemic that has so far spread to nearly every Bangladeshi district.

Bangladesh recorded 112 deaths from COVID-19 on April 19, its highest daily toll from the pandemic, the government said.

On Wednesday, the country’s Directorate General of Health Services (DGHS) reported 2,955 new cases of COVID-19 and 77 new deaths, bringing the number of total cases to 754,614 and the total death toll to 11,305.

To limit the second wave of the pandemic, Bangladesh on Wednesday extended the ongoing lockdown again by one week to May 5. Enditem

About Xinhua Silk Road

Xinhua Silk Road (en.imsilkroad.com) is the Belt and Road Initiative (BRI) portal.China’s silk road economic belt and the 21st century maritime silk road website,includes BRI Policy, BRI Trade, BRI Investment, Belt and Road weekly, Know Belt and Road, and the integrated information services for the Belt and Road Initiative (BRI).

Source: Bangladesh approves proposal of producing Russian, Chinese COVID-19 vaccines

Comments

Popular posts from this blog

Singapore’s manufacturing output declines 0.9 pct on year in October

Abstract : Singapore Economic Development Board announced on Thursday that the country's manufacturing output decreased 0.9 percent year on year in October, compared to a revised 25.6 percent rise in September. SINGAPORE, Nov. 26 (Xinhua) — Singapore Economic Development Board announced on Thursday that the country’s manufacturing output decreased 0.9 percent year on year in October, compared to a revised 25.6 percent rise in September. Excluding biomedical manufacturing, the output fell 2.7 percent in October from a year ago. On a seasonally adjusted month-on-month basis, Singapore’s manufacturing output decreased 19 percent in October. Excluding biomedical manufacturing, the output fell 2.9 percent. As for the performance of different clusters, the electronics cluster’s output fell 0.6 percent year on year in October, compared to a revised 33.1 percent increase in September. The biomedical manufacturing cluster saw its output grow 10.2 percent in October, compared to a revi...

China’s Greater Bay Area to take lead in traditional medicines

Abstract : Guangdong, Hong Kong and Macao will strengthen cooperation in building a "highland" for the traditional Chinese medicine (TCM) sector, according to an official plan unveiled on Thursday. GUANGZHOU, Oct. 23 (Xinhua) — Guangdong, Hong Kong and Macao will strengthen cooperation in building a “highland” for the traditional Chinese medicine (TCM) sector, according to an official plan unveiled on Thursday. The plan was jointly released by the National Administration of Traditional Chinese Medicine, the office of the leading group for the development of the Guangdong-Hong Kong-Macao Greater Bay Area and the provincial government of Guangdong. According to the plan, the bay area aims to take the lead in innovation, industry development and personnel training of TCM, as well as promoting its internationalization. The region plans to build a group of high-level TCM hospitals by 2022 and help several well-known local TCM brands enter the global market. By 2025, the inter...

Economic Watch: China’s industrial profits rebound, pressure persists

Abstract : Profits of China's major industrial firms rebounded in the second quarter (Q2) as business activities continued to pick up, but the recovery still faces uncertainties due to the global spread of COVID-19. BEIJING, July 27 (Xinhua) — Profits of China’s major industrial firms rebounded in the second quarter (Q2) as business activities continued to pick up, but the recovery still faces uncertainties due to the global spread of COVID-19 . In Q2, profits of industrial companies with annual revenue of more than 20 million yuan (about 2.86 million U.S. dollars) rose by 4.8 percent year on year, reversing the 36.7-percent decline in Q1, the National Bureau of Statistics (NBS) said on Monday. In June alone, major industrial firms saw their profits rise by 11.5 percent to 666.55 billion yuan, widening by 5.5 percentage points from that in May, said NBS senior statistician Zhu Hong. The quickened growth in industrial production and sales, as well as the moderate drop in the fa...